CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 149 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,200,865 | +330.8% | 30,279 | +198.9% | 0.00% | +100.0% |
| Q3 2023 | $278,778 | -29.4% | 10,130 | -13.0% | 0.00% | 0.0% |
| Q2 2023 | $394,877 | +51.4% | 11,638 | +98.8% | 0.00% | – |
| Q4 2022 | $260,868 | -57.5% | 5,853 | -73.2% | 0.00% | -100.0% |
| Q3 2022 | $614,000 | +4.4% | 21,843 | +0.1% | 0.00% | -50.0% |
| Q2 2022 | $588,000 | -65.8% | 21,811 | -56.8% | 0.00% | -66.7% |
| Q1 2022 | $1,719,000 | +14.9% | 50,487 | +82.1% | 0.01% | +20.0% |
| Q3 2021 | $1,496,000 | +976.3% | 27,718 | +158.7% | 0.01% | – |
| Q2 2020 | $139,000 | – | 10,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |